EATG » CHMP recommends for approval generic version of Atripla

CHMP recommends for approval generic version of Atripla

At its May meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended for approval a generic version of Atripla – Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (efavirenz/emtricitabine/tenofovir disoproxil) for the treatment of HIV infection.

Summary of opinion for Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva is available here.

Source:
EMA
News categories: HIV treatment, EMA/FDA